Clinical Trial Update: Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate [Phase 3]

View source ↗

Summary

Phase III study evaluating safety and efficacy of Fermagate with Lanthanum Carbonate for chronic kidney disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Fermagate
• LANTHANUM CARBONATE (lanthanum carbonate)

Snippet

Sponsor: Ineos Healthcare Limited | Conditions: Chronic Kidney Failure | Phase 3 | Status: TERMINATED